Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Artivion, Inc.
Agreement with Alexion is JCR’s first international deal for its blood-brain barrier drug delivery technology. Sartoris buys PolyPlus from private equity investors.
China has cleared for sale the world's first inhaled vaccine for COVID-19, as China continues to face challenges to its strict "COVID Zero" policies, including a new extended lockdown in a major city, ahead of the upcoming high-stakes National Congress.
When the German major bought AskBio a couple of years ago, one of its assets was a gene therapy for Huntington’s, a devastating disease that leads to complete physical and mental deterioration. That asset, BV-101, is about to enter the clinic.
The performances of the leading medtechs in the first year of the COVID-19 pandemic were impossible to compare and certainly unrepresentative of normal business cycles and competitive activity. Elective care was largely put on hold and emergency needs boosted exceptional demand for certain product types. More than anything else, 2020 tested management skills and planning.
- Implantable Devices
- Other Names / Subsidiaries
- CryoLife, Inc.
- Cardiogenesis Corporation
- CryoLife Asia Pacific, Pte. Ltd.
- CryoLife Europa Ltd
- CryoLife France, SAS
- JOTEC AG
- JOTEC Cardiovascular SL.
- JOTEC Polska Sp. z o.o.
- JOTEC s.r.l.
- On-X Life Technologies Holdings, Inc.
- Ascyrus Medical LLC
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.